JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hechler, V.
Right arrow Articles by Maitre, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hechler, V.
Right arrow Articles by Maitre, M.

Vol. 281, Issue 2, 753-760, 1997

gamma -Hydroxybutyrate Conversion into GABA Induces Displacement of GABAB Binding that is Blocked by Valproate and Ethosuximide1

Viviane Hechler, Charline Ratomponirina and Michel Maitre

L.N.M.I.C, UPR 416 CNRS, Centre de Neurochimie, Strasbourg Cedex, France

gamma -Hydroxybutyrate (GHB) has been reported to be a ligand for GABAB receptor(s), although with low or very low affinity (IC50 = 150-796 µM). In addition, several reports argue for a role of GHB via GABAB receptors in both in vivo and in vitro electrophysiological experiments. In the present study, we demonstrate that the inhibition of GHB's conversion into GABA by rat brain membranes blocks the ability of GHB to interfere with GABAB binding. In particular, the inhibition of GHB dehydrogenase by valproate or ethosuximide and the blockade of GABA-T by aminooxyacetic acid induce the disappearance of the GABA-like effect of GHB at GABAB, but also at GABAA, receptors. This finding could explain the misinterpretation of in vi&tacute;ro or in vivo experiments where GHB possesses a GABA-like effect. But in addition, it is postulated that the normal metabolism of GHB in brain induces GABAB mechanisms that could be blocked by the administration of valproate or ethosuximide.


Copyright © by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
Q. Wang, X. Wang, and M. E. Morris
Effects of L-Lactate and D-Mannitol on {gamma}-Hydroxybutyrate Toxicokinetics and Toxicodynamics in Rats
Drug Metab. Dispos., November 1, 2008; 36(11): 2244 - 2251.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. Wellendorph, S. Hog, J. R. Greenwood, A. de Lichtenberg, B. Nielsen, B. Frolund, L. Brehm, R. P. Clausen, and H. Brauner-Osborne
Novel Cyclic {gamma}-Hydroxybutyrate (GHB) Analogs with High Affinity and Stereoselectivity of Binding to GHB Sites in Rat Brain
J. Pharmacol. Exp. Ther., October 1, 2005; 315(1): 346 - 351.
[Abstract] [Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
J. Rodgers, C. H. Ashton, E. Gilvarry, and A. H. Young
Liquid ecstasy: a new kid on the dance floor
The British Journal of Psychiatry, February 2, 2004; 184(2): 104 - 106.
[Full Text] [PDF]


Home page
J. Neurosci.Home page
N. Gervasi, Z. Monnier, P. Vincent, D. Paupardin-Tritsch, S. W. Hughes, V. Crunelli, and N. Leresche
Pathway-Specific Action of {gamma}-Hydroxybutyric Acid in Sensory Thalamus and Its Relevance to Absence Seizures
J. Neurosci., December 10, 2003; 23(36): 11469 - 11478.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Ren and I. Mody
{gamma}-Hydroxybutyrate Reduces Mitogen-activated Protein Kinase Phosphorylation via GABAB Receptor Activation in Mouse Frontal Cortex and Hippocampus
J. Biol. Chem., October 24, 2003; 278(43): 42006 - 42011.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. E. Breitkreuz, W. L. Allan, O. R. Van Cauwenberghe, C. Jakobs, D. Talibi, B. Andre, and B. J. Shelp
A Novel {gamma}-Hydroxybutyrate Dehydrogenase: IDENTIFICATION AND EXPRESSION OF AN ARABIDOPSIS cDNA AND POTENTIAL ROLE UNDER OXYGEN DEFICIENCY
J. Biol. Chem., October 17, 2003; 278(42): 41552 - 41556.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
H. Wu, N. Zink, L. P. Carter, A. K. Mehta, R. J. Hernandez, M. K. Ticku, R. Lamb, C. P. France, and A. Coop
A Tertiary Alcohol Analog of gamma -Hydroxybutyric Acid as a Specific gamma -Hydroxybutyric Acid Receptor Ligand
J. Pharmacol. Exp. Ther., May 1, 2003; 305(2): 675 - 679.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. P. Carter, L. R. Flores, H. Wu, W. Chen, A. W. Unzeitig, A. Coop, and C. P. France
The Role of GABAB Receptors in the Discriminative Stimulus Effects of gamma -Hydroxybutyrate in Rats: Time Course and Antagonism Studies
J. Pharmacol. Exp. Ther., May 1, 2003; 305(2): 668 - 674.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. K. Mehta, N. M. Muschaweck, D. Y. Maeda, A. Coop, and M. K. Ticku
Binding Characteristics of the gamma -Hydroxybutyric Acid Receptor Antagonist [3H](2E)-(5-Hydroxy-5,7,8,9-tetrahydro-6H-benzo[a][7]annulen-6-ylidene) Ethanoic Acid in the Rat Brain
J. Pharmacol. Exp. Ther., December 1, 2001; 299(3): 1148 - 1153.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Gobaille, V. Hechler, C. Andriamampandry, V. Kemmel, and M. Maitre
gamma -Hydroxybutyrate Modulates Synthesis and Extracellular Concentration of gamma -Aminobutyric Acid in Discrete Rat Brain Regions In Vivo
J. Pharmacol. Exp. Ther., July 1, 1999; 290(1): 303 - 309.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
T. E. Madden and S. W. Johnson
Gamma-Hydroxybutyrate is a GABAB Receptor Agonist that Increases a Potassium Conductance in Rat Ventral Tegmental Dopamine Neurons
J. Pharmacol. Exp. Ther., October 1, 1998; 287(1): 261 - 265.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics.